A Personal Neoantigen Vaccine Neo-Pv-01 In Combination With Chemotherapy And Pembrolizumab Induces Broad De Novo Immune Responses In First-Line Non-Squamous Nsclc: Associations With Clinical Outcomes

CANCER RESEARCH(2021)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要